|
Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
|
Details of activity:
|
Active against multidrug-resistant Staphylococcus aureus, Bacillus athracis, Corynebacterium xerosis, Lactobacillus casei, Lactobacillus acidophilus, Streptococcus pneumoniae, Enterococcus faecalis, and Haemophilus influenzae (only Gram-negative it is active against)
|
|
Description:
|
Natural product from Streptomyces albolongus; a glycosylated antibiotic; shows in vivo activity against staphylococcal infection in mice but severe local tissue toxicity in animals had been reported; chemically unstable
|
|
Institute where first reported:
|
Bristol-Banyu Research Institute, Ltd.
|
|
Year first mentioned:
|
1964
|
|
Development status:
|
Experimental
|